ETF Monitors


Weekly ETF Monitor for week ending 17 December 2021


This week's highlights

  • In a week that saw technology stocks lead global markets lower, ETFS Ultra Short Nasdaq 100 Hedge Fund (SNAS) was the week’s overall top performing fund, up 8.3%. ETFS S&P Biotech ETF (CURE) gained 5.7% as global concerns over the Omicron variant intensified. Mining and resources funds (MNRS, OZR, GDX and QRE) and domestic property funds (VAP and SLF) were also amongst the top performers. Crypto-related funds DIGA and CRYP were the week’s poorest performing ETFs, followed by a range of technology and energy-related funds.

  • Precious metals gained ground, with GOLD ending the week 1.8% higher. Silver fund ETPMAG was the week’s top performing commodity ETP, up 3.7%.

  • Total reported flows into domestically domiciled ETFs were $351m, while outflows totalled $123m. The largest inflows for the week were into broad-based global equity fund IWLD, followed by cash fund AAA. Australian equity fund IOZ saw the largest outflows for the week.

  • VAS was the most traded fund for the week, followed by AAA.

  • ETFS S&P Biotech ETF (CURE) offers investors exposure to U.S. healthcare biotechnology companies. To be eligible for inclusion in the index, companies must be part of the biotechnology sub-industry of the U.S. healthcare sector and meet minimum market capitalisation and liquidity requirements.